Peptide may usher nanoparticles past immune system into tumors

02/25/2013 | Nature (free content)

University of Pennsylvania researchers have designed molecules bearing a segment of the membrane protein CD47, which tricks macrophages into allowing drug-bearing nanoparticles into blood cells, according to a study published in Science. The researchers designed a 21-amino-acid peptide based on the CD47 sequence and attached it to polystyrene nanobeads that also included a dye that can be identified using fluorescence spectroscopy. Tests on mice showed the nanobeads sneak past immune cells and accumulate in tumors. Researchers hope the technique can be improved to employ customized nanobeads.

View Full Article in:

Nature (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC